Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,418 | -1,359 | -6,557 | -5,880 | -4,613 |
| Depreciation Amortization | 30 | 17 | 69 | 52 | 34 |
| Accounts payable and accrued liabilities | 300 | 201 | -130 | 125 | 538 |
| Other Working Capital | 520 | 394 | -670 | -362 | 309 |
| Other Operating Activity | 373 | 143 | 2,518 | 1,860 | 963 |
| Operating Cash Flow | $-1,195 | $-604 | $-4,770 | $-4,205 | $-2,769 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -18 | N/A | N/A | N/A |
| Investing Cash Flow | $-18 | $-18 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -60 | N/A | 14,098 | 14,170 | 1,898 |
| Other Financing Activity | 0 | -60 | 0 | 0 | 0 |
| Financing Cash Flow | $-60 | $-60 | $14,098 | $14,170 | $1,898 |
| Beginning Cash Position | 19,807 | 19,807 | 10,479 | 10,479 | 10,479 |
| End Cash Position | 18,534 | 19,125 | 19,807 | 20,444 | 9,608 |
| Net Cash Flow | $-1,273 | $-682 | $9,328 | $9,965 | $-871 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,195 | -604 | -4,770 | -4,205 | -2,769 |
| Capital Expenditure | -18 | -18 | N/A | N/A | 0 |
| Free Cash Flow | -1,213 | -622 | -4,770 | -4,205 | -2,769 |